紫杉醇加顺铂同步放化疗治疗局部晚期非小细胞肺癌的临床观察  

Paclitaxel Plus Cisplatin Combined with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

作　　者：王继营[1] 李峻[1] 仲荣达[1] 李崇阳[1] 田丹[1] 

机构地区：[1]云南省第二人民医院肿瘤科

出　　处：《肿瘤预防与治疗》2009年第1期19-21,共3页Journal of Cancer Control And Treatment

摘　　要：目的:探讨紫杉醇加顺铂同步放化疗治疗局部晚期非小细胞肺癌(NSCLC)的疗效和毒副反应。方法:32例患者行常规分割放疗40Gy,针对局部病灶行三维适形放疗(3DCRT)加量至中位总剂量达70Gy/35次。化疗方案为紫杉醇135mg/m2静脉滴注第1天,顺铂20mg/m2静脉滴注,第1天～4天。结果:全组32例均可评价疗效,总有效率(CR+PR)为71.9%。中位缓解期为8.6个月,中位生存期为15.2个月,1年、2年的生存率分别为68.8%和46.9%。主要毒性反应为白细胞减少,Ⅲ度16例(50.0%),Ⅳ度3例(9.7%)。急性放射性肺炎1级～2级13例(40.6%);急性放射性食管炎1级～2级17例(53.1%),3级2例(6.3%)。结论:紫杉醇加顺铂同步放化疗治疗局部晚期NSCLC局控率较高,骨髓毒副反应较明显,急性放射性损伤在大多数患者尚可耐受。Objective:To evaluate the acute side effects and clinical efficacy of paclitaxel (PTX) plus cisplatin (DDP) combined with concurrent radiotherapy for locally advanced non-small cell lung cancer.Methods: 32 patients with locally advanced NSCLC were given PTX 135mg/m2 by intravenous infusion on day 1, and DDP 20mg/m2 by intravenous infusion on day 1-4. At the same time, they received conventional radiotherapy and 3DCRT to total dose of 70Gy/35f.Results: The response rate(RR) was71.9%.Median TTP was 8.6 months...

关 键 词：非小细胞肺癌 放、化疗法 常规/三维适形放疗 

分 类 号：R734.2[医药卫生—肿瘤]